Baltimore -- The immunosuppressant agent mycophenolate mofetil (CellCept) should be considered the steroid-sparing drug of choice in the management of pemphigus, according to Daniel Mimouni, M.D.
Advancements in Understanding the Skin's Microbiomes
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Narrow-Spectrum Antibiotics: The Precision Medicine of Acne?
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
New Advancements in Surgical Scar Revision
New Data Shows Promising Results in Treatment of Hand and Foot Atopic Dermatitis